MINNEAPOLIS--(BUSINESS WIRE)--Raymedica, the Pioneer in Nucleus Arthroplasty, today announced it will present first phase clinical results from a 10-patient clinical evaluation of it’s new HydraFlex Nucleus Arthroplasty System™ at the 7th Annual Spine Arthroplasty Society (SAS7) Conference in Berlin, Germany. Raymedica is evaluating the benefits of the HydraFlex Technology for patients with early degenerative disc disease. The clinical evaluation, conducted in Mexico City by Alejandro Reyes-Sanchez, MD, at the Instituto Nacional de Rehabilitación will be presented at the Raymedica SAS7 Workshop, May 2nd, Salon 16, Riga Room at 12:35 PM.
